je.st
news
Gains In Cardiac Rhythm Management Devices Offset By Lower Pricing
2013-02-06 10:26:43| drugdiscoveryonline Home Page
The rising incidence of lifestyle diseases such as diabetes and obesity, an ageing population and the prevalence of cardiovascular diseases such as arrhythmia, heart failure and atrial fibrillation, have expanded the patient pool for cardiac rhythm management (CRM) devices in both Europe and the United States.
Tags: management
lower
devices
pricing
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||